Measuring ACPA in the general population or primary care: is it useful?

Rheumatoid arthritis (RA) is associated with a significant disease burden and high costs for society. Because the disease has identifiable preclinical stages, screening and prevention have become a possibility in RA. Anticitrullinated peptide antibodies (ACPAs) are arguably the most likely candidate...

Descripción completa

Detalles Bibliográficos
Autores principales: Finckh, Axel, Courvoisier, Delphine, Lamacchia, Celine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046970/
https://www.ncbi.nlm.nih.gov/pubmed/32079664
http://dx.doi.org/10.1136/rmdopen-2019-001085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046970/
https://www.ncbi.nlm.nih.gov/pubmed/32079664
http://dx.doi.org/10.1136/rmdopen-2019-001085

Ejemplares similares